Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Supply, Demand and Key Producers, 2023-2029

Page: 102

Published Date: 28 Feb 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

The global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13), and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) total production and demand, 2018-2029, (K Units)
Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) total production value, 2018-2029, (USD Million)
Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) domestic production, consumption, key domestic manufacturers and share
Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Minhai Bio, Kexing Bio, Cansino Bio and Lanzhou Biological Preparations Institute, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market, Segmentation by Type
    Serotype 6B
    7F Serotype
    Serotype 9V
    14 Serotype
    Serotype 18C
    Serotype 19A
    19F Serotype
    23F Serotype
    24F Serotype
    Other

Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market, Segmentation by Application
    Infants from 6 Weeks to 15 Months Old
    Children Aged 15 Months to 5 Years

Companies Profiled:
    Pfizer
    Minhai Bio
    Kexing Bio
    Cansino Bio
    Lanzhou Biological Preparations Institute

Key Questions Answered
1. How big is the global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) market?
2. What is the demand of the global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) market?
3. What is the year over year growth of the global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) market?
4. What is the production and production value of the global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) market?
5. Who are the key producers in the global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Introduction
    1.2 World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Supply & Forecast
        1.2.1 World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Value (2018 & 2022 & 2029)
        1.2.2 World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production (2018-2029)
        1.2.3 World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Pricing Trends (2018-2029)
    1.3 World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production by Region (Based on Production Site)
        1.3.1 World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Value by Region (2018-2029)
        1.3.2 World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production by Region (2018-2029)
        1.3.3 World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Average Price by Region (2018-2029)
        1.3.4 North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production (2018-2029)
        1.3.5 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production (2018-2029)
        1.3.6 China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production (2018-2029)
        1.3.7 Japan 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Demand (2018-2029)
    2.2 World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption by Region
        2.2.1 World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption by Region (2018-2023)
        2.2.2 World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Forecast by Region (2024-2029)
    2.3 United States 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption (2018-2029)
    2.4 China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption (2018-2029)
    2.5 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption (2018-2029)
    2.6 Japan 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption (2018-2029)
    2.7 South Korea 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption (2018-2029)
    2.8 ASEAN 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption (2018-2029)
    2.9 India 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption (2018-2029)

3 World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Manufacturers Competitive Analysis
    3.1 World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Value by Manufacturer (2018-2023)
    3.2 World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production by Manufacturer (2018-2023)
    3.3 World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Average Price by Manufacturer (2018-2023)
    3.4 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) in 2022
        3.5.3 Global Concentration Ratios (CR8) for 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) in 2022
    3.6 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market: Overall Company Footprint Analysis
        3.6.1 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market: Region Footprint
        3.6.2 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market: Company Product Type Footprint
        3.6.3 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Value Comparison
        4.1.1 United States VS China: 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Value Comparison (2018 & 2022 & 2029)
        4.1.2 United States VS China: 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Value Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States VS China: 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Comparison
        4.2.1 United States VS China: 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States VS China: 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Comparison
        4.3.1 United States VS China: 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Comparison (2018 & 2022 & 2029)
        4.3.2 United States VS China: 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Market Share Comparison (2018 & 2022 & 2029)
    4.4 United States Based 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Manufacturers and Market Share, 2018-2023
        4.4.1 United States Based 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Value (2018-2023)
        4.4.3 United States Based Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production (2018-2023)
    4.5 China Based 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Manufacturers and Market Share
        4.5.1 China Based 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Value (2018-2023)
        4.5.3 China Based Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production (2018-2023)
    4.6 Rest of World Based 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Manufacturers and Market Share, 2018-2023
        4.6.1 Rest of World Based 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Value (2018-2023)
        4.6.3 Rest of World Based Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production (2018-2023)

5 Market Analysis by Type
    5.1 World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Serotype 6B
        5.2.2 7F Serotype
        5.2.3 Serotype 9V
        5.2.4 14 Serotype
        5.2.5 Serotype 18C
        5.2.6 Serotype 19A
        5.2.7 19F Serotype
        5.2.8 23F Serotype
        5.2.9 24F Serotype
        5.2.10 Other
    5.3 Market Segment by Type
        5.3.1 World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production by Type (2018-2029)
        5.3.2 World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Value by Type (2018-2029)
        5.3.3 World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Average Price by Type (2018-2029)

6 Market Analysis by Application
    6.1 World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Infants from 6 Weeks to 15 Months Old
        6.2.2 Children Aged 15 Months to 5 Years
    6.3 Market Segment by Application
        6.3.1 World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production by Application (2018-2029)
        6.3.2 World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Value by Application (2018-2029)
        6.3.3 World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Average Price by Application (2018-2029)

7 Company Profiles
    7.1 Pfizer
        7.1.1 Pfizer Details
        7.1.2 Pfizer Major Business
        7.1.3 Pfizer 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product and Services
        7.1.4 Pfizer 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.1.5 Pfizer Recent Developments/Updates
        7.1.6 Pfizer Competitive Strengths & Weaknesses
    7.2 Minhai Bio
        7.2.1 Minhai Bio Details
        7.2.2 Minhai Bio Major Business
        7.2.3 Minhai Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product and Services
        7.2.4 Minhai Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.2.5 Minhai Bio Recent Developments/Updates
        7.2.6 Minhai Bio Competitive Strengths & Weaknesses
    7.3 Kexing Bio
        7.3.1 Kexing Bio Details
        7.3.2 Kexing Bio Major Business
        7.3.3 Kexing Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product and Services
        7.3.4 Kexing Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.3.5 Kexing Bio Recent Developments/Updates
        7.3.6 Kexing Bio Competitive Strengths & Weaknesses
    7.4 Cansino Bio
        7.4.1 Cansino Bio Details
        7.4.2 Cansino Bio Major Business
        7.4.3 Cansino Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product and Services
        7.4.4 Cansino Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.4.5 Cansino Bio Recent Developments/Updates
        7.4.6 Cansino Bio Competitive Strengths & Weaknesses
    7.5 Lanzhou Biological Preparations Institute
        7.5.1 Lanzhou Biological Preparations Institute Details
        7.5.2 Lanzhou Biological Preparations Institute Major Business
        7.5.3 Lanzhou Biological Preparations Institute 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product and Services
        7.5.4 Lanzhou Biological Preparations Institute 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.5.5 Lanzhou Biological Preparations Institute Recent Developments/Updates
        7.5.6 Lanzhou Biological Preparations Institute Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Industry Chain
    8.2 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Upstream Analysis
        8.2.1 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Core Raw Materials
        8.2.2 Main Manufacturers of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Mode
    8.6 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Procurement Model
    8.7 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Industry Sales Model and Sales Channels
        8.7.1 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Model
        8.7.2 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Value by Region (2018, 2022 and 2029) & (USD Million)
    Table 2. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Value by Region (2018-2023) & (USD Million)
    Table 3. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Value by Region (2024-2029) & (USD Million)
    Table 4. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Value Market Share by Region (2018-2023)
    Table 5. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Value Market Share by Region (2024-2029)
    Table 6. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production by Region (2018-2023) & (K Units)
    Table 7. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production by Region (2024-2029) & (K Units)
    Table 8. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Market Share by Region (2018-2023)
    Table 9. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Market Share by Region (2024-2029)
    Table 10. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Average Price by Region (2018-2023) & (US$/Unit)
    Table 11. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Average Price by Region (2024-2029) & (US$/Unit)
    Table 12. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Major Market Trends
    Table 13. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
    Table 14. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption by Region (2018-2023) & (K Units)
    Table 15. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Forecast by Region (2024-2029) & (K Units)
    Table 16. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Value by Manufacturer (2018-2023) & (USD Million)
    Table 17. Production Value Market Share of Key 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Producers in 2022
    Table 18. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production by Manufacturer (2018-2023) & (K Units)
    Table 19. Production Market Share of Key 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Producers in 2022
    Table 20. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 21. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Company Evaluation Quadrant
    Table 22. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Industry Rank of Major Manufacturers, Based on Production Value in 2022
    Table 23. Head Office and 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Site of Key Manufacturer
    Table 24. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market: Company Product Type Footprint
    Table 25. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market: Company Product Application Footprint
    Table 26. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Competitive Factors
    Table 27. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) New Entrant and Capacity Expansion Plans
    Table 28. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Mergers & Acquisitions Activity
    Table 29. United States VS China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 30. United States VS China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 31. United States VS China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 32. United States Based 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Value, (2018-2023) & (USD Million)
    Table 34. United States Based Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Value Market Share (2018-2023)
    Table 35. United States Based Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production (2018-2023) & (K Units)
    Table 36. United States Based Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Market Share (2018-2023)
    Table 37. China Based 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Value, (2018-2023) & (USD Million)
    Table 39. China Based Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Value Market Share (2018-2023)
    Table 40. China Based Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production (2018-2023) & (K Units)
    Table 41. China Based Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Market Share (2018-2023)
    Table 42. Rest of World Based 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Value, (2018-2023) & (USD Million)
    Table 44. Rest of World Based Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Value Market Share (2018-2023)
    Table 45. Rest of World Based Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production (2018-2023) & (K Units)
    Table 46. Rest of World Based Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Market Share (2018-2023)
    Table 47. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 48. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production by Type (2018-2023) & (K Units)
    Table 49. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production by Type (2024-2029) & (K Units)
    Table 50. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Value by Type (2018-2023) & (USD Million)
    Table 51. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Value by Type (2024-2029) & (USD Million)
    Table 52. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Average Price by Type (2018-2023) & (US$/Unit)
    Table 53. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Average Price by Type (2024-2029) & (US$/Unit)
    Table 54. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 55. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production by Application (2018-2023) & (K Units)
    Table 56. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production by Application (2024-2029) & (K Units)
    Table 57. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Value by Application (2018-2023) & (USD Million)
    Table 58. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Value by Application (2024-2029) & (USD Million)
    Table 59. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Average Price by Application (2018-2023) & (US$/Unit)
    Table 60. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Average Price by Application (2024-2029) & (US$/Unit)
    Table 61. Pfizer Basic Information, Manufacturing Base and Competitors
    Table 62. Pfizer Major Business
    Table 63. Pfizer 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product and Services
    Table 64. Pfizer 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 65. Pfizer Recent Developments/Updates
    Table 66. Pfizer Competitive Strengths & Weaknesses
    Table 67. Minhai Bio Basic Information, Manufacturing Base and Competitors
    Table 68. Minhai Bio Major Business
    Table 69. Minhai Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product and Services
    Table 70. Minhai Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 71. Minhai Bio Recent Developments/Updates
    Table 72. Minhai Bio Competitive Strengths & Weaknesses
    Table 73. Kexing Bio Basic Information, Manufacturing Base and Competitors
    Table 74. Kexing Bio Major Business
    Table 75. Kexing Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product and Services
    Table 76. Kexing Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. Kexing Bio Recent Developments/Updates
    Table 78. Kexing Bio Competitive Strengths & Weaknesses
    Table 79. Cansino Bio Basic Information, Manufacturing Base and Competitors
    Table 80. Cansino Bio Major Business
    Table 81. Cansino Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product and Services
    Table 82. Cansino Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 83. Cansino Bio Recent Developments/Updates
    Table 84. Lanzhou Biological Preparations Institute Basic Information, Manufacturing Base and Competitors
    Table 85. Lanzhou Biological Preparations Institute Major Business
    Table 86. Lanzhou Biological Preparations Institute 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product and Services
    Table 87. Lanzhou Biological Preparations Institute 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 88. Global Key Players of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Upstream (Raw Materials)
    Table 89. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Typical Customers
    Table 90. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Typical Distributors
List of Figure
    Figure 1. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Picture
    Figure 2. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Value: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Value and Forecast (2018-2029) & (USD Million)
    Figure 4. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production (2018-2029) & (K Units)
    Figure 5. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Average Price (2018-2029) & (US$/Unit)
    Figure 6. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Value Market Share by Region (2018-2029)
    Figure 7. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Market Share by Region (2018-2029)
    Figure 8. North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production (2018-2029) & (K Units)
    Figure 9. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production (2018-2029) & (K Units)
    Figure 10. China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production (2018-2029) & (K Units)
    Figure 11. Japan 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production (2018-2029) & (K Units)
    Figure 12. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption (2018-2029) & (K Units)
    Figure 15. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Market Share by Region (2018-2029)
    Figure 16. United States 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption (2018-2029) & (K Units)
    Figure 17. China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption (2018-2029) & (K Units)
    Figure 18. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption (2018-2029) & (K Units)
    Figure 19. Japan 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption (2018-2029) & (K Units)
    Figure 20. South Korea 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption (2018-2029) & (K Units)
    Figure 21. ASEAN 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption (2018-2029) & (K Units)
    Figure 22. India 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption (2018-2029) & (K Units)
    Figure 23. Producer Shipments of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) by Manufacturer Revenue ($MM) and Market Share (%): 2022
    Figure 24. Global Four-firm Concentration Ratios (CR4) for 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Markets in 2022
    Figure 25. Global Four-firm Concentration Ratios (CR8) for 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Markets in 2022
    Figure 26. United States VS China: 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 27. United States VS China: 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. United States Based Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Market Share 2022
    Figure 30. China Based Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Market Share 2022
    Figure 31. Rest of World Based Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Market Share 2022
    Figure 32. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 33. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Value Market Share by Type in 2022
    Figure 34. Serotype 6B
    Figure 35. 7F Serotype
    Figure 36. Serotype 9V
    Figure 37. 14 Serotype
    Figure 38. Serotype 18C
    Figure 39. Serotype 19A
    Figure 40. 19F Serotype
    Figure 41. 23F Serotype
    Figure 42. 24F Serotype
    Figure 43. Other
    Figure 44. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Market Share by Type (2018-2029)
    Figure 45. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Value Market Share by Type (2018-2029)
    Figure 46. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Average Price by Type (2018-2029) & (US$/Unit)
    Figure 47. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 48. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Value Market Share by Application in 2022
    Figure 49. Infants from 6 Weeks to 15 Months Old
    Figure 50. Children Aged 15 Months to 5 Years
    Figure 51. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Market Share by Application (2018-2029)
    Figure 52. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Value Market Share by Application (2018-2029)
    Figure 53. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Average Price by Application (2018-2029) & (US$/Unit)
    Figure 54. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Industry Chain
    Figure 55. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Procurement Model
    Figure 56. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Model
    Figure 57. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Channels, Direct Sales, and Distribution
    Figure 58. Methodology
    Figure 59. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 08 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Product Tags

13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13)

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>